SPECIFIC PHARMA A/S: Financial statements 2025
CVR: 33161395
Source: annual report 2025, Danish Business Authority
01/02/2024 – 31/01/2025
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 219,329,000 and a net result of DKK 29,239,000 compared with DKK 25,560,000 the year before. That is an increase of 4% compared with the year before. The profit margin was 13.3%. Equity in the 2025 report amounted to DKK 111,203,000. The solvency ratio was 82.7%. The company had 28 employees in the financial year.
- Revenue
- DKK 219,329,000
- Gross Profit
- DKK 57,275,000
- Profit/Loss
- DKK 29,239,000
- Equity
- DKK 111,203,000
- Total Assets
- DKK 134,475,000
- Employees
- 28
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 219.3 mio. | 57.3 mio. | 29.2 mio. | 111.2 mio. | 28 |
| 2024 | 211 mio. | 48.5 mio. | 25.6 mio. | 106.2 mio. | 25 |
| 2023 | 177.6 mio. | 34.7 mio. | 9.9 mio. | 89.6 mio. | 25 |
| 2022 | 123.3 mio. | 26.4 mio. | 7.8 mio. | 85.5 mio. | 23 |
| 2021 | 139.6 mio. | 32.5 mio. | 14.8 mio. | 88.8 mio. | 21 |
Official annual report
How creditworthy is SPECIFIC PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of June 26, 2025, Forvis Mazars Statsautoriseret Revisionspartnerselskab has been appointed auditor of SPECIFIC PHARMA A/S.
As of June 26, 2025, EY Godkendt Revisionspartnerselskab has stepped down as auditor of SPECIFIC PHARMA A/S.
SPECIFIC PHARMA A/S has won the tender "Amgros 2025 1.295.a" issued by Amgros I/S worth 19,893,718 DKK.
About SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.